Roche’s live audio webcast on Gazyva in lupus nephritis presented at ASN/ACR 2019

Tuesday, 12 November 2019

Audio webcast replay

Downloads

Presentation

Additional information

Invitation

Related links

Investor updates

All

Published on: 13 November 2019

Invitation to Roche’s live audio webcast and conference call on key hematology data presented at ASH 2019

more

Published on: 11 November 2019

Roche’s Gazyva (obinutuzumab), in combination with standard of care, more than doubles the percentage of lupus nephritis patients achieving complete renal response, compared to standard of care alone

more

Published on: 11 November 2019

Roche’s risdiplam meets primary endpoint in pivotal SUNFISH trial in people with type 2 or 3 spinal muscular atrophy

more

IR events

All

21November

Jefferies Global Healthcare Conference

(GMT)

London, UK

add to calendar

4December

Berenberg European Conference

(GMT)

London, UK

add to calendar

4December

Evercore ISI 2nd Annual HealthConX

(PDT)

Boston, US

add to calendar

Share price

Latest annual report

Annual Report 2018 Highlights

How digital innovation increases patient benefit in the future

more

Finance information tool

more

Pipeline

Pipeline

Get up-to-date information about our pipeline.

more

Roche R&D

more

Genentech Biooncology

more

Diagnostics

Diagnostics overview

Get an introduction to our Diagnostics business.

more

Sustainability

Sustainability download center

more

Sustainability at Roche

more

Non-financial reporting

more

Dividend and total return

Dividend calendar

Timetable for payment of the 2018 dividend

more

Total return center

Investor tool providing analysis of total returns

more

Frequently asked questions

FAQ

Get answers to frequently asked questions

more

US investors

How to invest

more

poster

Message from our CEO

“The foundation of our success is and will remain our clear focus on innovation.”

Contact